Optical coherence tomography in coronary atherosclerosis assessment and intervention

M Araki, SJ Park, HL Dauerman, S Uemura… - Nature Reviews …, 2022 - nature.com
Since optical coherence tomography (OCT) was first performed in humans two decades ago,
this imaging modality has been widely adopted in research on coronary atherosclerosis and …

Principles of intravascular lithotripsy for calcific plaque modification

DJ Kereiakes, R Virmani, JY Hokama, U Illindala… - Cardiovascular …, 2021 - jacc.org
A significant proportion of lesions treated with transcatheter interventions in the coronary
and peripheral vascular beds exhibit moderate to severe calcific plaques known to portend …

Cardiovascular calcification heterogeneity in chronic kidney disease

JD Hutcheson, C Goettsch - Circulation Research, 2023 - Am Heart Assoc
Patients with chronic kidney disease (CKD) exhibit tremendously elevated risk for
cardiovascular disease, particularly ischemic heart disease, due to premature vascular and …

Intravascular lithotripsy for treatment of calcified coronary lesions: patient-level pooled analysis of the disrupt CAD studies

DJ Kereiakes, C Di Mario, RF Riley, J Fajadet… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this pooled analysis was to assess the cumulative safety and
effectiveness of coronary intravascular lithotripsy (IVL). Background The clinical outcomes of …

Intravascular Lithotripsy for Vessel Preparation in Severely Calcified Coronary Arteries Prior to Stent Placement―Primary Outcomes From the Japanese Disrupt CAD …

S Saito, S Yamazaki, A Takahashi, A Namiki… - Circulation …, 2021 - jstage.jst.go.jp
Background: Intravascular lithotripsy (IVL) delivers acoustic pressure waves to modify
calcium, enhance vessel compliance and optimize stent deployment. The objective of this …

[HTML][HTML] Management of in-stent restenosis

F Alfonso, JJ Coughlan, D Giacoppo, A Kastrati… - …, 2022 - ncbi.nlm.nih.gov
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

[HTML][HTML] In stent neo-atherosclerosis: pathophysiology, clinical implications, prevention, and therapeutic approaches

A Nusca, MM Viscusi, F Piccirillo, A De Filippis… - Life, 2022 - mdpi.com
Despite the dramatic improvements of revascularization therapies occurring in the past
decades, a relevant percentage of patients treated with percutaneous coronary intervention …

[HTML][HTML] Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry

MNT Forero, G Sardella, N Salvi, B Cortese… - …, 2022 - ncbi.nlm.nih.gov
Background Stent underexpansion increases the risk of cardiac adverse events. At present,
there are limited options to treat refractory stent underexpansion. In this context, the …

Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group

E Barbato, E Gallinoro, M Abdel-Wahab… - European Heart …, 2023 - academic.oup.com
Since the publication of the 2015 EAPCI consensus on rotational atherectomy, the number
of percutaneous coronary interventions (PCI) performed in patients with severely calcified …

[HTML][HTML] Intravascular lithotripsy for the treatment of stent underexpansion: the multicenter IVL-DRAGON registry

W Wańha, M Tomaniak, P Wańczura, J Bil… - Journal of Clinical …, 2022 - mdpi.com
Background: Whereas the efficacy and safety of intravascular lithotripsy (IVL) have been
confirmed in de novo calcified coronary lesions, little is known about its utility in treating stent …